Indefinite Delivery Contract SPE2DX15D5019

This indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp is a single-award contract valued up to $999,999,999 that runs through December 2025. The contract serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded task orders cover a variety of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and diagnostic test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain treatment, and infectious disease prevention. This IDC enables the DLA to efficiently procure critical pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. No set-aside requirements were used, reflecting AmerisourceBergen's strong position as a leading pharmaceutical distributor serving the federal government.

In addition to the DLA Troop Support Medical IDC, AmerisourceBergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse pharmaceutical and medical supply needs of multiple government agencies on a large scale, leveraging its extensive distribution network and expertise in the federal healthcare market.